Fig. 1From: DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial Schematic of study design for the adult (A) and pediatric (B) enrollment. Pharmacokinetic (PK); severe adverse events (SAEs); adverse events (AEs); continuous electroencephalogram (cEEG); magnetic resonance imaging (MRI); transcranial doppler (TCD); lumbar puncture (LP); post-intervention (p.i.)Back to article page